Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Summary
The CLEAR LABELS Act would amend the Federal Food, Drug, and Cosmetic Act so that every packaged drug must show the name, location and unique ID of its original manufacturer, as well as the packer or distributor, either directly on the label or via a QR code linking to an electronic portal. It also exempts these drugs from the usual customs country‑of‑origin marking rules. The bill targets pharmaceutical companies and aims to give consumers clearer information about where their medicines come from.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when HR 8269 changes status, plus AI-powered summaries and stage predictions.
Sign up free